[Form 4] Aptevo Therapeutics Inc Insider Trading Activity
Aptevo Therapeutics director Grant Grady III reported a grant of 7,200 Restricted Stock Units (RSUs) in a Form 4 covering a transaction dated 08/06/2025. The RSUs convert one-for-one into common stock and are reported as direct holdings of 7,200 shares following the grant. The RSUs vest in full on the first anniversary of the grant.
The form is signed by attorney-in-fact SoYoung Kwon on 08/08/2025, and the filing shows a $0 price for the RSUs.
Il direttore di Aptevo Therapeutics, Grant Grady III, ha riportato in un Modulo 4 la concessione di 7,200 Restricted Stock Units (RSU) relativa a una transazione datata 08/06/2025. Le RSU si convertono una a una in azioni ordinarie e sono indicate come partecipazione diretta pari a 7,200 azioni dopo la concessione. Le RSU maturano integralmente al primo anniversario della data di assegnazione.
Il modulo 猫 firmato per procura da SoYoung Kwon in data 08/08/2025 e la presentazione riporta un prezzo di $0 per le RSU.
El director de Aptevo Therapeutics, Grant Grady III, registr贸 en un Formulario 4 la concesi贸n de 7.200 Restricted Stock Units (RSU) en una operaci贸n con fecha 08/06/2025. Las RSU se convierten una a una en acciones ordinarias y se informan como una tenencia directa de 7.200 acciones tras la concesi贸n. Las RSU vencen por completo en el primer aniversario de la concesi贸n.
El formulario est谩 firmado por el apoderado SoYoung Kwon el 08/08/2025, y la presentaci贸n indica un precio de $0 por las RSU.
Aptevo Therapeutics鞚� 鞚挫偓 Grant Grady III电� 08/06/2025 鞛� 瓯半灅鞐� 雽�頃� 7,200臧滌潣 Restricted Stock Units (RSUs) 攵�鞐ゼ Form 4鞐� 氤搓碃頄堨姷雼堧嫟. 鞚� RSU电� 氤错喌欤茧 1:1搿� 鞝勴櫂霅橂┌, 攵�鞐� 頉� 7,200欤检潣 歆侅为 氤挫湢搿� 氤搓碃霅╇媹雼�. RSU电� 攵�鞐澕搿滊秬韯� 觳� 氩堨Ц 旮半厫鞚检棎 鞝勳暋 頄夓偓霅╇媹雼�.
頃措嫻 靹滌嫕鞚� 08/08/2025鞐� 雽�毽澑(Attorney-in-fact) SoYoung Kwon鞚� 靹滊獏頄堨溂氅�, 鞝滌稖靹滌棎电� RSU 臧�瓴╈澊 $0鞙茧 旮办灛霅橃柎 鞛堨姷雼堧嫟.
Le directeur d'Aptevo Therapeutics, Grant Grady III, a d茅clar茅 dans un Formulaire 4 une attribution de 7 200 Restricted Stock Units (RSU) pour une op茅ration dat茅e du 08/06/2025. Les RSU se convertissent une pour une en actions ordinaires et sont d茅clar茅es comme une d茅tention directe de 7 200 actions apr猫s l'attribution. Les RSU deviennent pleinement acquises au premier anniversaire de l'attribution.
Le formulaire est sign茅 par le mandataire SoYoung Kwon le 08/08/2025, et le d茅p么t indique un prix de $0 pour les RSU.
Der Direktor von Aptevo Therapeutics, Grant Grady III, meldete in einem Form 4 die Gew盲hrung von 7.200 Restricted Stock Units (RSUs) f眉r eine Transaktion mit Datum 08/06/2025. Die RSUs wandeln sich eins zu eins in Stammaktien um und werden nach der Gew盲hrung als direkte Beteiligung von 7.200 Aktien ausgewiesen. Die RSUs werden am ersten Jahrestag der Gew盲hrung vollst盲ndig unverfallbar.
Das Formular ist am 08/08/2025 vom Bevollm盲chtigten SoYoung Kwon unterschrieben, und die Einreichung gibt einen Preis von $0 f眉r die RSUs an.
- None.
- None.
Insights
TL;DR: Director Grant Grady III received 7,200 RSUs that convert 1:1 to common stock with one-year vesting; appears routine and non-material.
The Form 4 documents a grant of 7,200 RSUs to a reporting director on 08/06/2025. The RSUs convert one-for-one into common shares and vest in full on the first anniversary of the grant. The filing reports these as direct holdings and lists a price of $0. Impact assessment: Not impactful based on the filing alone; this reads as a standard director equity award disclosed under Section 16.
TL;DR: Standard RSU award to a director with clear vesting schedule and Section 16 disclosure; no governance concerns evident from the filing.
The disclosure identifies the reporting person as a Director and provides explicit terms: conversion at a one-for-one rate and full vesting on the first anniversary. The Form 4 is signed by an attorney-in-fact on 08/08/2025. Impact assessment: Not impactful; the filing meets routine disclosure expectations and contains no indications of unusual transfer, sale, or derivative activity.
Il direttore di Aptevo Therapeutics, Grant Grady III, ha riportato in un Modulo 4 la concessione di 7,200 Restricted Stock Units (RSU) relativa a una transazione datata 08/06/2025. Le RSU si convertono una a una in azioni ordinarie e sono indicate come partecipazione diretta pari a 7,200 azioni dopo la concessione. Le RSU maturano integralmente al primo anniversario della data di assegnazione.
Il modulo 猫 firmato per procura da SoYoung Kwon in data 08/08/2025 e la presentazione riporta un prezzo di $0 per le RSU.
El director de Aptevo Therapeutics, Grant Grady III, registr贸 en un Formulario 4 la concesi贸n de 7.200 Restricted Stock Units (RSU) en una operaci贸n con fecha 08/06/2025. Las RSU se convierten una a una en acciones ordinarias y se informan como una tenencia directa de 7.200 acciones tras la concesi贸n. Las RSU vencen por completo en el primer aniversario de la concesi贸n.
El formulario est谩 firmado por el apoderado SoYoung Kwon el 08/08/2025, y la presentaci贸n indica un precio de $0 por las RSU.
Aptevo Therapeutics鞚� 鞚挫偓 Grant Grady III电� 08/06/2025 鞛� 瓯半灅鞐� 雽�頃� 7,200臧滌潣 Restricted Stock Units (RSUs) 攵�鞐ゼ Form 4鞐� 氤搓碃頄堨姷雼堧嫟. 鞚� RSU电� 氤错喌欤茧 1:1搿� 鞝勴櫂霅橂┌, 攵�鞐� 頉� 7,200欤检潣 歆侅为 氤挫湢搿� 氤搓碃霅╇媹雼�. RSU电� 攵�鞐澕搿滊秬韯� 觳� 氩堨Ц 旮半厫鞚检棎 鞝勳暋 頄夓偓霅╇媹雼�.
頃措嫻 靹滌嫕鞚� 08/08/2025鞐� 雽�毽澑(Attorney-in-fact) SoYoung Kwon鞚� 靹滊獏頄堨溂氅�, 鞝滌稖靹滌棎电� RSU 臧�瓴╈澊 $0鞙茧 旮办灛霅橃柎 鞛堨姷雼堧嫟.
Le directeur d'Aptevo Therapeutics, Grant Grady III, a d茅clar茅 dans un Formulaire 4 une attribution de 7 200 Restricted Stock Units (RSU) pour une op茅ration dat茅e du 08/06/2025. Les RSU se convertissent une pour une en actions ordinaires et sont d茅clar茅es comme une d茅tention directe de 7 200 actions apr猫s l'attribution. Les RSU deviennent pleinement acquises au premier anniversaire de l'attribution.
Le formulaire est sign茅 par le mandataire SoYoung Kwon le 08/08/2025, et le d茅p么t indique un prix de $0 pour les RSU.
Der Direktor von Aptevo Therapeutics, Grant Grady III, meldete in einem Form 4 die Gew盲hrung von 7.200 Restricted Stock Units (RSUs) f眉r eine Transaktion mit Datum 08/06/2025. Die RSUs wandeln sich eins zu eins in Stammaktien um und werden nach der Gew盲hrung als direkte Beteiligung von 7.200 Aktien ausgewiesen. Die RSUs werden am ersten Jahrestag der Gew盲hrung vollst盲ndig unverfallbar.
Das Formular ist am 08/08/2025 vom Bevollm盲chtigten SoYoung Kwon unterschrieben, und die Einreichung gibt einen Preis von $0 f眉r die RSUs an.
FAQ
What insider transaction did Aptevo (APVO) report?
How many shares will the RSUs convert into for APVO?
What price was reported for the RSU grant on the Form 4?
Who signed the Form 4 for this APVO filing?
What is the reporting person's role at Aptevo?
